Neutrophil activation marker CD15+ as a prognostic factor of ocular surface damage in type 2 diabetics. Ukr. j. ophthalmol. [Internet]. 2024 Feb. 29 [cited 2026 Aug. 9];(1):15-9. Available from: https://ua.ozhurnal.com/index.php/files/article/view/80